Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

ClinicalTrials.gov ID: NCT00036270

Public ClinicalTrials.gov record NCT00036270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen For 2.5- 3 Years Followed By Exemestane (Aromasin) For A Total Of 5 Years As Adjuvant Therapy For Postmenopausal, Receptor Positive, Node Negative or Node Positive Breast Cancer Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effects of exemestane for 5 years versus tamoxifen and exemestane given sequentially over 5 years in the adjuvant treatment of postmenopausal women with early breast cancer. This Pfizer sponsored trial is part of an international collaboration of investigators conducting 7 similar yet independent studies in 9 countries. This study is designed to be part of the larger TEAM trial where the data from these 7 studies will be combined. A pre-specified analysis of the pooled data will be conducted.

Study identification

NCT ID
NCT00036270
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
9,779 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2001
Primary completion
Sep 30, 2008
Completion
Jan 31, 2011
Last update posted
Oct 27, 2015

2001 – 2011

United States locations

U.S. sites
179
U.S. states
25
U.S. cities
142
Facility City State ZIP Site status
Pfizer Investigational Site Bessemer Alabama 35022
Pfizer Investigational Site Birmingham Alabama 35205
Pfizer Investigational Site Birmingham Alabama 35209
Pfizer Investigational Site Birmingham Alabama 35211
Pfizer Investigational Site Birmingham Alabama 35213
Pfizer Investigational Site Birmingham Alabama 35235
Pfizer Investigational Site Flagstaff Arizona 86001
Pfizer Investigational Site Green Valley Arizona 85614
Pfizer Investigational Site Oro Valley Arizona 85737
Pfizer Investigational Site Phoenix Arizona 85012
Pfizer Investigational Site Safford Arizona 85546
Pfizer Investigational Site Scottsdale Arizona 85258
Pfizer Investigational Site Sedona Arizona 86336
Pfizer Investigational Site Tucson Arizona 85710
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Tucson Arizona 85745
Pfizer Investigational Site Tuscon Arizona 85704
Pfizer Investigational Site North Little Rock Arkansas 72117
Pfizer Investigational Site Aurora Colorado 80012
Pfizer Investigational Site Boulder Colorado 80303
Pfizer Investigational Site Colorado Springs Colorado 80909
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Denver Colorado 80220
Pfizer Investigational Site Fort Collins Colorado *0524
Pfizer Investigational Site Lakewood Colorado 80228
Pfizer Investigational Site Lone Tree Colorado 80124
Pfizer Investigational Site Longmont Colorado 80501
Pfizer Investigational Site Pueblo Colorado 81008
Pfizer Investigational Site Thornton Colorado 80260-
Pfizer Investigational Site Clearwater Florida 33761
Pfizer Investigational Site Hudson Florida 34667
Pfizer Investigational Site Jacksonville Florida 32204
Pfizer Investigational Site Jacksonville Florida 32207
Pfizer Investigational Site Lauderhill Florida 33319
Pfizer Investigational Site Melbourne Florida 32901
Pfizer Investigational Site New Port Richey Florida 34655
Pfizer Investigational Site Ocala Florida 34474
Pfizer Investigational Site Orange Park Florida 32073
Pfizer Investigational Site Palatka Florida 32177
Pfizer Investigational Site Plantation Florida 33324
Pfizer Investigational Site Saint Augustine Florida 32086
Pfizer Investigational Site Alton Illinois 62002
Pfizer Investigational Site Arlington Heights Illinois �60005
Pfizer Investigational Site Niles Illinois 60714
Pfizer Investigational Site Winfield Illinois 60190
Pfizer Investigational Site Carmel Indiana 46032
Pfizer Investigational Site Fishers Indiana 46037
Pfizer Investigational Site Greenfield Indiana 46140
Pfizer Investigational Site Indianapolis Indiana 46219
Pfizer Investigational Site Indianapolis Indiana 46227
Pfizer Investigational Site Shelbyville Indiana 46176
Pfizer Investigational Site Terre Haute Indiana 47802
Pfizer Investigational Site Cedar Rapids Iowa 52403
Pfizer Investigational Site Kansas City Kansas 66112
Pfizer Investigational Site Shawnee Mission Kansas 66204
Pfizer Investigational Site Westminster Maryland 21157
Pfizer Investigational Site North Adams Massachusetts 01247
Pfizer Investigational Site Pittsfield Massachusetts 01201
Pfizer Investigational Site Burnsville Minnesota 55337
Pfizer Investigational Site Edina Minnesota 55435-2150
Pfizer Investigational Site Maplewood Minnesota 55109
Pfizer Investigational Site Saint Paul Minnesota 55102-2389
Pfizer Investigational Site Woodbury Minnesota 55125
Pfizer Investigational Site Columbia Missouri 65201
Pfizer Investigational Site Kansas City Missouri 64111
Pfizer Investigational Site Kansas City Missouri 64131
Pfizer Investigational Site Kansas City Missouri 64154
Pfizer Investigational Site Lee's Summit Missouri 29307
Pfizer Investigational Site Lee's Summit Missouri 64064
Pfizer Investigational Site St Louis Missouri 63136
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Santa Fe New Mexico 87505
Pfizer Investigational Site Albany New York 12206
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Amsterdam New York 12010
Pfizer Investigational Site Brockport New York 14420
Pfizer Investigational Site Canandaigua New York 14424
Pfizer Investigational Site Geneva New York 14456
Pfizer Investigational Site Hudson New York 12534
Pfizer Investigational Site Latham New York 12110-0610
Pfizer Investigational Site Rexford New York 12148
Pfizer Investigational Site Troy New York 12180
Pfizer Investigational Site Asheville North Carolina 28801
Pfizer Investigational Site Cary North Carolina 27518
Pfizer Investigational Site Durham North Carolina 27704
Pfizer Investigational Site Elizabeth City North Carolina 27909
Pfizer Investigational Site Hickory North Carolina 28602
Pfizer Investigational Site Kernersville North Carolina 27284
Pfizer Investigational Site Lexington North Carolina 27295
Pfizer Investigational Site Raleigh North Carolina 27607
Pfizer Investigational Site Raleigh North Carolina 27614
Pfizer Investigational Site Seneca North Carolina 29672
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Kettering Ohio 45409
Pfizer Investigational Site Bartlesville Oklahoma 74006
Pfizer Investigational Site Norman Oklahoma 73071
Pfizer Investigational Site Oklahoma City Oklahoma 73102
Pfizer Investigational Site Oklahoma City Oklahoma 73104-5020
Pfizer Investigational Site Oklahoma City Oklahoma 73109
Pfizer Investigational Site Oklahoma City Oklahoma 73112-4416
Pfizer Investigational Site Tulsa Oklahoma 74104
Pfizer Investigational Site Tulsa Oklahoma 74133
Pfizer Investigational Site Tulsa Oklahoma 74136
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Portland Oregon 97213-2996
Pfizer Investigational Site Portland Oregon 97216
Pfizer Investigational Site Portland Oregon 97225
Pfizer Investigational Site Springfield Oregon 97477
Pfizer Investigational Site Tualatin Oregon 97062
Pfizer Investigational Site Kingston Pennsylvania 18704-5535
Pfizer Investigational Site Easley South Carolina 29640
Pfizer Investigational Site Greenville South Carolina 29605
Pfizer Investigational Site Greenville South Carolina 29615
Pfizer Investigational Site Spartanburg South Carolina 29307
Pfizer Investigational Site Abilene Texas 79606-5208
Pfizer Investigational Site Arlington Texas 76012
Pfizer Investigational Site Arlington Texas 76014
Pfizer Investigational Site Austin Texas 78731
Pfizer Investigational Site Austin Texas 78745
Pfizer Investigational Site Beaumont Texas 77702-1449
Pfizer Investigational Site Bedford Texas 76022'
Pfizer Investigational Site Dallas Texas 75230-2510
Pfizer Investigational Site Dallas Texas 75231-4400
Pfizer Investigational Site Dallas Texas 75237
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Denton Texas 76210
Pfizer Investigational Site El Paso Texas 79902
Pfizer Investigational Site El Paso Texas 79915
Pfizer Investigational Site Fort Worth Texas 76104
Pfizer Investigational Site Fredericksburg Texas 78624
Pfizer Investigational Site Garland Texas 75042
Pfizer Investigational Site Houston Texas 77024
Pfizer Investigational Site Irving Texas 75061-224
Pfizer Investigational Site Kerrville Texas 78028
Pfizer Investigational Site Lewisville Texas 75067
Pfizer Investigational Site Longview Texas 75601
Pfizer Investigational Site McAllen Texas 78503
Pfizer Investigational Site Mesquite Texas 75150
Pfizer Investigational Site Midland Texas 79701
Pfizer Investigational Site New Braunfels Texas 78130
Pfizer Investigational Site Odessa Texas 79761
Pfizer Investigational Site Paris Texas 75460-5004
Pfizer Investigational Site Plano Texas 75075-7787
Pfizer Investigational Site Round Rock Texas 78681
Pfizer Investigational Site San Antonio Texas 78212
Pfizer Investigational Site San Antonio Texas 78217
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site San Antonio Texas 78258-3912
Pfizer Investigational Site Sherman Texas TX 75090-0504
Pfizer Investigational Site Tyler Texas 75702
Pfizer Investigational Site Waco Texas 76712
Pfizer Investigational Site Webster Texas 77598
Pfizer Investigational Site Weslaco Texas 78596
Pfizer Investigational Site Wichita Falls Texas 76310
Pfizer Investigational Site Chesapeake Virginia 23320
Pfizer Investigational Site Christianburg, Virginia 24073
Pfizer Investigational Site Christianburg Virginia 24073
Pfizer Investigational Site Fairfax Virginia 22031
Pfizer Investigational Site Gainesville Virginia 20155
Pfizer Investigational Site Hampton Virginia 23666
Pfizer Investigational Site Newport News Virginia 23606
Pfizer Investigational Site Norfolk Virginia 23502
Pfizer Investigational Site Pulaski Virginia 24301
Pfizer Investigational Site Roanoke Virginia 24101
Pfizer Investigational Site Salem Virginia 24153
Pfizer Investigational Site Williamsburg Virginia 23188
Pfizer Investigational Site Woodbridge Virginia 22191
Pfizer Investigational Site Wytheville Virginia 24382
Pfizer Investigational Site Burien Washington 98166
Pfizer Investigational Site Edmonds Washington 98026
Pfizer Investigational Site Seattle Washington 98133-8414
Pfizer Investigational Site Seattle Washington 98133
Pfizer Investigational Site Spokane Washington 99202
Pfizer Investigational Site Spokane Washington 99216
Pfizer Investigational Site Spokane Washington 99218
Pfizer Investigational Site Vancouver Washington 98684-6930
Pfizer Investigational Site Vancouver Washington 98684
Pfizer Investigational Site Vancouver Washington 98686

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2015 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00036270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →